BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15890841)

  • 1. cAMP and extracellular signal-regulated kinase signaling in response to d-amphetamine and methylphenidate in the prefrontal cortex in vivo: role of beta 1-adrenoceptors.
    Pascoli V; Valjent E; Corbillé AG; Corvol JC; Tassin JP; Girault JA; Hervé D
    Mol Pharmacol; 2005 Aug; 68(2):421-9. PubMed ID: 15890841
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase A-dependent mechanism in cultured rat spinal microglia.
    Morioka N; Tanabe H; Inoue A; Dohi T; Nakata Y
    Neurochem Int; 2009 Sep; 55(4):226-34. PubMed ID: 19524113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nobiletin, a citrus flavonoid, reverses learning impairment associated with N-methyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling.
    Nakajima A; Yamakuni T; Matsuzaki K; Nakata N; Onozuka H; Yokosuka A; Sashida Y; Mimaki Y; Ohizumi Y
    J Pharmacol Exp Ther; 2007 May; 321(2):784-90. PubMed ID: 17289833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 4'-Demethylnobiletin, a bioactive metabolite of nobiletin enhancing PKA/ERK/CREB signaling, rescues learning impairment associated with NMDA receptor antagonism via stimulation of the ERK cascade.
    Al Rahim M; Nakajima A; Saigusa D; Tetsu N; Maruyama Y; Shibuya M; Yamakoshi H; Tomioka Y; Iwabuchi Y; Ohizumi Y; Yamakuni T
    Biochemistry; 2009 Aug; 48(32):7713-21. PubMed ID: 19601643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine D(1) and D(3) receptors oppositely regulate NMDA- and cocaine-induced MAPK signaling via NMDA receptor phosphorylation.
    Jiao H; Zhang L; Gao F; Lou D; Zhang J; Xu M
    J Neurochem; 2007 Oct; 103(2):840-8. PubMed ID: 17897358
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epinephrine stimulates esophageal squamous-cell carcinoma cell proliferation via beta-adrenoceptor-dependent transactivation of extracellular signal-regulated kinase/cyclooxygenase-2 pathway.
    Liu X; Wu WK; Yu L; Sung JJ; Srivastava G; Zhang ST; Cho CH
    J Cell Biochem; 2008 Sep; 105(1):53-60. PubMed ID: 18452159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of acute and chronic administration of atomoxetine and methylphenidate on extracellular levels of noradrenaline, dopamine and serotonin in the prefrontal cortex and striatum of mice.
    Koda K; Ago Y; Cong Y; Kita Y; Takuma K; Matsuda T
    J Neurochem; 2010 Jul; 114(1):259-70. PubMed ID: 20403082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo electrophysiological effects of methylphenidate in the prefrontal cortex: involvement of dopamine D1 and alpha 2 adrenergic receptors.
    Gronier B
    Eur Neuropsychopharmacol; 2011 Feb; 21(2):192-204. PubMed ID: 21146374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 68930 and dihydrexidine inhibit locomotor activity and d-amphetamine-induced hyperactivity in rats: a role of inhibitory dopamine D(1/5) receptors in the prefrontal cortex?
    Isacson R; Kull B; Wahlestedt C; Salmi P
    Neuroscience; 2004; 124(1):33-42. PubMed ID: 14960337
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of serotonin 2A receptors in the D-amphetamine-induced release of dopamine: comparison with previous data on alpha1b-adrenergic receptors.
    Auclair A; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 2004 Oct; 91(2):318-26. PubMed ID: 15447665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. D1 but not D2 dopamine receptors or adrenoceptors mediate dopamine-induced potentiation of N-methyl-d-aspartate currents in the rat prefrontal cortex.
    Wirkner K; Krause T; Köles L; Thümmler S; Al-Khrasani M; Illes P
    Neurosci Lett; 2004 Nov; 372(1-2):89-93. PubMed ID: 15531094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent effect of CDPPB, the mGluR5 positive allosteric modulator, on recognition memory is associated with GluR1 and CREB phosphorylation in the prefrontal cortex and hippocampus.
    Uslaner JM; Parmentier-Batteur S; Flick RB; Surles NO; Lam JS; McNaughton CH; Jacobson MA; Hutson PH
    Neuropharmacology; 2009; 57(5-6):531-8. PubMed ID: 19627999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nicotine-induced phosphorylation of ERK in mouse primary cortical neurons: evidence for involvement of glutamatergic signaling and CaMKII.
    Steiner RC; Heath CJ; Picciotto MR
    J Neurochem; 2007 Oct; 103(2):666-78. PubMed ID: 17666046
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes-induced mechanical hyperalgesia involves spinal mitogen-activated protein kinase activation in neurons and microglia via N-methyl-D-aspartate-dependent mechanisms.
    Daulhac L; Mallet C; Courteix C; Etienne M; Duroux E; Privat AM; Eschalier A; Fialip J
    Mol Pharmacol; 2006 Oct; 70(4):1246-54. PubMed ID: 16868181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mice with chronic norepinephrine deficiency resemble amphetamine-sensitized animals.
    Weinshenker D; Miller NS; Blizinsky K; Laughlin ML; Palmiter RD
    Proc Natl Acad Sci U S A; 2002 Oct; 99(21):13873-7. PubMed ID: 12370425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine promotes cortical Up state: Role of adrenergic receptors.
    Shen G; Shi WX
    Addict Biol; 2021 Jan; 26(1):e12879. PubMed ID: 32003119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychostimulants and atomoxetine alter the electrophysiological activity of prefrontal cortex neurons, interaction with catecholamine and glutamate NMDA receptors.
    Di Miceli M; Gronier B
    Psychopharmacology (Berl); 2015 Jun; 232(12):2191-205. PubMed ID: 25572531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Involvement of a dysfunctional dopamine-D1/N-methyl-d-aspartate-NR1 and Ca2+/calmodulin-dependent protein kinase II pathway in the impairment of latent learning in a model of schizophrenia induced by phencyclidine.
    Mouri A; Noda Y; Noda A; Nakamura T; Tokura T; Yura Y; Nitta A; Furukawa H; Nabeshima T
    Mol Pharmacol; 2007 Jun; 71(6):1598-609. PubMed ID: 17344353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of methylphenidate on the catecholaminergic system in attention-deficit/hyperactivity disorder.
    Wilens TE
    J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S46-53. PubMed ID: 18480677
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral and biochemical responses to d-amphetamine in MCH1 receptor knockout mice.
    Smith DG; Qi H; Svenningsson P; Wade M; Davis RJ; Gehlert DR; Nomikos GG
    Synapse; 2008 Feb; 62(2):128-36. PubMed ID: 18000809
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.